Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial” - Takeaways - MDSpire

Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial”

  • October 16, 2024

  • 0 min

Share

  • 1

    An erratum was issued for the article on low-dose methotrexate and methimazole in Graves' disease.

  • 2

    The original abstract incorrectly stated the dosage of methotrexate as 10 mg/d.

  • 3

    The corrected dosage of methotrexate is now stated as 10 mg/w.

  • 4

    The correction affects the understanding of the treatment regimen in the study.

  • 5

    The corrected article is available online with the updated information.

Original Source(s)

Correction to: “Effects of Low-dose Methotrexate With Methimazole in Patients With Graves’ Disease: Results of a Randomized Clinical Trial”

  • October 16, 2024

Related Content

When Thyroid and Parathyroid Collide

Pathologists report the first case of papillary thyroid carcinoma invading an intrathyroidal parathyroid adenoma

Multi-Class Classification of Thyroid Disorders Utilizing Modified DenseNet-201 and Tc-99m Scintigraphy Through Deep Learning Techniques

AACE 2026: AI advances in thyroid care face barriers to adoption

Emerging tools show strong diagnostic potential—but validation, workflow integration, and reimbursement challenges remain.